Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by LivaNova PLC
< Previous
1
2
Next >
LivaNova to Announce Second-Quarter 2023 Results
June 14, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
June 13, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2023 Results
May 03, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Board of Directors Announce Leadership Changes
April 14, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2023 Results
March 22, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
March 09, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Barclays Global Healthcare Conference
March 09, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
February 22, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
February 08, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Launches SenTiva DUO
February 03, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
January 18, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
December 13, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
November 30, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
November 17, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
November 08, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Third-Quarter 2022 Results
November 02, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Third-Quarter 2022 Results
September 21, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Board Appoints Brooke Story as a New Director
September 15, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Second-Quarter 2022 Results
August 03, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Second-Quarter 2022 Results
June 22, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Elects Peter Wilver to Board of Directors
June 14, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
May 25, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2022 Results
May 04, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
April 08, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2022 Results
March 24, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study
March 14, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
February 24, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results
February 23, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results
January 12, 2022
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting
December 02, 2021
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.